ofollow">institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.
For more information about Quorum Review, visit http://www.quorumreview.com.
About Consent Solutions
Consent Solutions has been spearheading the development and adoption of electronic consent in the clinical space since 2003. The result of extensive and ongoing research with patients, sponsors, regulatory bodies, CROs and IRBs, the Consent Solutions platform, SecureConsent, takes a patient-centered approach that is supported by video and electronic multimedia to facilitate and enhance patient comprehension. Backed by tightly controlled administrative procedures and controls, granular tracking, sophisticated version control and multi-lingual support, the SecureConsent ecosystem tackles many of the problems of paper-based consenting.
For more information about Consent Solutions, visit http://www.consentsolutions.com.
Page: 1 2 3 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Quorum Review IRB Board Chair Appointed to SACHRP2
. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems3
. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae4
. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 20125
. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 20126
. Nonprofit Consortium Publishes Review of Skullcap Adulteration7
. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.8
. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 20129
. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials10
. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 201211
. Alzheimers Therapeutics Reviewed by NeuroPerspective